✦ LIBER ✦

Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle

✍ Scribed by J. Lokich; N. Anderson; M. Bern; C. Moore

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 328 KB
Volume: 67
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910215)67:4<883::aid-cncr2820670404>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of continuous infusion c

A phase I trial of continuous infusion cisplatin

✍ Marshall R. Posner; Laura Ferrari; James F. Belliveau; Francis J. Cummings; Mich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Cyclophosphamide, methotrexate, and 5-fl

Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion

✍ Jacob Lokich; Murray Bern; Norwood Anderson; Sabina Wallach; Cherie Moore; Karen 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

A phase I clinical trial of combined flu

A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation

✍ N. Anderson; J. Lokich; M. Bern; S. Wallach; C. Moore; D. Williams 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

Two consecutive Phase I trials of continuous infusion 5-fluorouracil (5-FU) or floxuridine (5-FUdR) admixed with leucovorin (LCV) were performed and involved 19 and 24 patients, respectively. The studies were carried out to identify the optimal dose rate of delivery for the two admixtures (5-FU + LC

A phase I study of ifosfamide with mesna

A phase I study of ifosfamide with mesna given daily for 3 consecutive days to children with malignant solid tumors

✍ Charles B. Pratt; William H. Meyer; Edwin C. Douglass; Laura Bowman; Judith Wili 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

A Phase I trial of h-ras antisense oligo

A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

✍ C. Casey Cunningham; Jon T. Holmlund; Richard S. Geary; T. Jesse Kwoh; Andrew Do 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Brachytherapy and continuous infusion 5-

Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial

✍ William A. See; Robert Dreicer; James A. Wheeler; Paula K. Forest; Stefan Loenin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

BACKGROUND. 5-fluorouracil (5-FU) is a known radiosensitizer that enhances efficacy, in vivo and in vitro, when administered during radiotherapy. The following study was performed to evaluate the toxicity of continuous infusion 5-FU administered concomitant with brachytherapy in patients with locall